Christine Ann Miller - 05 Jan 2022 Form 4 Insider Report for IVERIC bio, Inc.

Role
Director
Signature
/s/ Todd Anderman, as Attorney-in-Fact for Christine Miller
Issuer symbol
N/A
Transactions as of
05 Jan 2022
Net transactions value
$0
Form type
4
Filing time
07 Jan 2022, 19:00:47 UTC
Next filing
16 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Stock Option (Right to Buy) Award $0 +31,000 $0.000000 31,000 05 Jan 2022 Common Stock 31,000 $14.31 Direct F1
transaction ISEE Restricted Stock Units Award $0 +15,000 $0.000000 15,000 05 Jan 2022 Common Stock 15,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the option will vest and become exercisable monthly with respect to 1/36th of the shares underlying such option until the third anniversary of the grant date.
F2 Each restricted stock unit represents the contingent right to receive one share of common stock of the Registrant upon vesting of the unit.
F3 Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of the restricted stock units will vest annually with respect to 1/3rd of the shares underlying such award until the third anniversary of the grant date.